相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of new small molecules as dual FoxM1 and Hsp70 inhibitors using computational methods
Zahra Alimardan et al.
RESEARCH IN PHARMACEUTICAL SCIENCES (2022)
An updated patent review of anticancer Hsp90 inhibitors (2013-present)
Li Li et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2021)
FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis
Dhanya Kalathil et al.
FRONTIERS IN ONCOLOGY (2021)
Function, Therapeutic Potential, and Inhibition of Hsp70 Chaperones
Andrew J. Ambrose et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Hsp70 in cancer: A double agent in the battle between survival and death
Mehdi A. Vostakolaei et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
New heat shock protein (Hsp90) inhibitors, designed by pharmacophore modeling and virtual screening: synthesis, biological evaluation and molecular dynamics studies
Maryam Abbasi et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer
Lipika Goyal et al.
INVESTIGATIONAL NEW DRUGS (2020)
Phase Ib trial of pembrolizumab and XL888 in patients with advanced gastrointestinal malignancies: Results of the dose-escalation phase.
Mehmet Akce et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Heat shock proteins as a new, promising target of multiple myeloma therapy
Sebastian Grosicki et al.
EXPERT REVIEW OF HEMATOLOGY (2020)
At the Crossroads of Apoptosis and Autophagy: Multiple Roles of the Co-Chaperone BAG3 in Stress and Therapy Resistance of Cancer
Donat Koegel et al.
CELLS (2020)
Understanding the Hsp90 N-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)
Ayanda M. Magwenyane et al.
MOLECULES (2020)
Membrane-Associated Heat Shock Proteins in Oncology: From Basic Research to New Theranostic Targets
Maxim Shevtsov et al.
CELLS (2020)
Heat Shock Protein 70 (HSP70) Induction: Chaperonotherapy for Neuroprotection after Brain Injury
Jong Youl Kim et al.
CELLS (2020)
Mechanistic Insights into the Role of Molecular Chaperones in Protein Misfolding Diseases: From Molecular Recognition to Amyloid Disassembly
Ruben Hervas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Spotlight on 17-AAG as an Hsp90 inhibitor for molecular targeted cancer treatment
Sona Talaei et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors
Akihiko Shimomura et al.
MOLECULAR CANCER THERAPEUTICS (2019)
The Hsp70-Hsp90 Chaperone Cascade in Protein Folding
Tania Moran Luengo et al.
TRENDS IN CELL BIOLOGY (2019)
The Role of HSP90 Chaperones in Stability and Plasticity of Ontogenesis of Plants under Normal and Stressful Conditions (Arabidopsis thaliana)
L. Y. Kozeko
CYTOLOGY AND GENETICS (2019)
A structure-activity relationship study of Forkhead Domain Inhibitors (FDI): The importance of halogen binding interactions
Seyed Amirhossein Tabatabaei Dakhili et al.
BIOORGANIC CHEMISTRY (2019)
Anti-tumor activity of neratinib, a pan-HER inhibitor, in gastric adenocarcinoma cells
Sepideh Hamzehlou et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
461PFirst in human phase I/IIa study of PEN-866, a heat shock protein 90 (HSP90) ligand – SN38 conjugate for patients with advanced solid tumours: Phase I results
J C Bendell et al.
ANNALS OF ONCOLOGY (2019)
HSP90 as a novel therapeutic target for posterior capsule opacification
Jing Li et al.
EXPERIMENTAL EYE RESEARCH (2019)
The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis
Paul Laissue
MOLECULAR CANCER (2019)
CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status
Carolina Rubio et al.
CLINICAL CANCER RESEARCH (2019)
Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds
Yvonne Ziegler et al.
NPJ BREAST CANCER (2019)
First-in-human study of the epichaperome inhibitor PU-H71: clinical results and metabolic profile
Giovanna Speranza et al.
INVESTIGATIONAL NEW DRUGS (2018)
CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought
Mary E. Klein et al.
CANCER CELL (2018)
Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches for further clinical development
Len Neckers et al.
CELL STRESS & CHAPERONES (2018)
Untying the knot of transcription factor druggability: Molecular modeling study of FOXM1 inhibitors
S. Amirhossein Tabatabaei-Dakhili et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2018)
Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non-Small Cell Lung Cancer
Enriqueta Felip et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance
Shang Yao et al.
SEMINARS IN CANCER BIOLOGY (2018)
Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer
Huafeng Pan et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)
Honokiol is a FOXM1 antagonist
Marianna Halasi et al.
CELL DEATH & DISEASE (2018)
Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations
Julia A. Yaglom et al.
SCIENTIFIC REPORTS (2018)
Honokiol: An anticancer lignan
Abdur Rauf et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Regulation of the master regulator FOXM1 in cancer
Guo-Bin Liao et al.
CELL COMMUNICATION AND SIGNALING (2018)
The HSP90 Family: Structure, Regulation, Function, and Implications in Health and Disease
Abdullah Hoter et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
NF-κB, inflammation, immunity and cancer: coming of age
Koji Taniguchi et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Discovery of Benzo[g]quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors
Mansour S. Alsaid et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma
Xue Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Hsp90β promoted endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma
Jing Meng et al.
MOLECULAR CANCER (2017)
The HSP90 chaperone machinery
Florian H. Schopf et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
The FOXM1 inhibitor RCM-1 suppresses goblet cell metaplasia and prevents IL-13 and STAT6 signaling in allergen-exposed mice
Lifeng Sun et al.
SCIENCE SIGNALING (2017)
The FOXM1 inhibitor RCM-1 suppresses goblet cell metaplasia and prevents IL-13 and STAT6 signaling in allergen-exposed mice
Lifeng Sun et al.
SCIENCE SIGNALING (2017)
Suppression of FOXM1 Transcriptional Activities via a Single-Stranded DNA Aptamer Generated by SELEX
Qin Xiang et al.
SCIENTIFIC REPORTS (2017)
FOXM1 in Cancer: Interactions and Vulnerabilities
Andrei L. Gartel
CANCER RESEARCH (2017)
A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESS
Marianna Halasi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Novel cyclic pentapeptide H-15 induces differentiation and inhibits proliferation in murine melanoma B16 cells
Yunjiang Liu et al.
ONCOLOGY LETTERS (2016)
A phase II study of the HSP90 inhibitor AUY922 in chemotherapy refractory advanced pancreatic cancer
D. J. Renouf et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
The human HSP70 family of chaperones: where do we stand?
Jurgen Radons
CELL STRESS & CHAPERONES (2016)
Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors
Katherine M. Byrd et al.
CHEMISTRY-A EUROPEAN JOURNAL (2016)
Targeting Allosteric Control Mechanisms in Heat Shock Protein 70 (Hsp70)
Xiaokai Li et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Caveolin-1 in the regulation of cell metabolism: a cancer perspective
Zeribe Chike Nwosu et al.
MOLECULAR CANCER (2016)
RB-independent activity of Cdk4/6 in bladder cancer
Daniel E. Castellano et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Estrogen Receptor Ligands: A Review (2013-2015)
Shabnam Farzaneh et al.
SCIENTIA PHARMACEUTICA (2016)
Small heat shock proteins: Role in cellular functions and pathology
Raman Bakthisaran et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
A Small Molecule Inhibitor of ATPase Activity of HSP70 Induces Apoptosis and Has Antitumor Activities
Sung-Kyun Ko et al.
CHEMISTRY & BIOLOGY (2015)
Validation of the Hsp70-Bag3 Protein-Protein Interaction as a Potential Therapeutic Target in Cancer
Xiaokai Li et al.
MOLECULAR CANCER THERAPEUTICS (2015)
First-in-Human Phase I Dose Escalation Study of a Second-Generation Non-Ansamycin HSP90 Inhibitor, AT13387, in Patients with Advanced Solid Tumors
Geoffrey I. Shapiro et al.
CLINICAL CANCER RESEARCH (2015)
Hsp70 in cancer: back to the future
M. Y. Sherman et al.
ONCOGENE (2015)
Structural Basis for the Inhibition of HSP70 and DnaK Chaperones by Small-Molecule Targeting of a C-Terminal Allosteric Pocket
Julia I-Ju Leu et al.
ACS CHEMICAL BIOLOGY (2014)
HER2 in Breast Cancer: A Review and Update
Uma Krishnamurti et al.
ADVANCES IN ANATOMIC PATHOLOGY (2014)
BIIB021, a novel Hsp90 inhibitor, sensitizes esophageal squamous cell carcinoma to radiation
Xin-Tong Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Human lysyl oxidase-like 2
Hee-Jung Moon et al.
BIOORGANIC CHEMISTRY (2014)
Hsp70-Bag3 Interactions Regulate Cancer-Related Signaling Networks
Teresa A. Colvin et al.
CANCER RESEARCH (2014)
Heat Shock Protein 70 Inhibitors. 1. 2,5′-Thiodipyrimidine and 5-(Phenylthio)pyrimidine Acrylamides as Irreversible Binders to an Allosteric Site on Heat Shock Protein 70
Yanlong Kang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Panepoxydone Targets NF-kB and FOXM1 to Inhibit Proliferation, Induce Apoptosis and Reverse Epithelial to Mesenchymal Transition in Breast Cancer
Ritu Arora et al.
PLOS ONE (2014)
A novel cyclic pentapeptide, H-10, inhibits B16 cancer cell growth and induces cell apoptosis
Geng Zhang et al.
ONCOLOGY LETTERS (2014)
Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition
Michael V. Gormally et al.
NATURE COMMUNICATIONS (2014)
Suppression of the Oncogenic Transcription Factor FOXM1 by Proteasome Inhibitors
Andrei L. Gartel
SCIENTIFICA (2014)
Allosteric Heat Shock Protein 70 Inhibitors Rapidly Rescue Synaptic Plasticity Deficits by Reducing Aberrant Tau
Jose Abisambra et al.
BIOLOGICAL PSYCHIATRY (2013)
Targeted inhibition of heat shock protein 90 disrupts multiple oncogenic signaling pathways, thus inducing cell cycle arrest and programmed cell death in human urinary bladder cancer cell lines
Panagiotis K. Karkoulis et al.
CANCER CELL INTERNATIONAL (2013)
A Phase I Study of the HSP90 Inhibitor Retaspimycin Hydrochloride (IPI-504) in Patients with Gastrointestinal Stromal Tumors or Soft-Tissue Sarcomas
Andrew J. Wagner et al.
CLINICAL CANCER RESEARCH (2013)
Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma
JulieAnn Rader et al.
CLINICAL CANCER RESEARCH (2013)
A Modified HSP70 Inhibitor Shows Broad Activity as an Anticancer Agent
Gregor M. Balaburski et al.
MOLECULAR CANCER RESEARCH (2013)
FOX(M1) News-It Is Cancer
Marianna Halasi et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Hsp70/Hsp90 chaperone machinery is involved in the assembly of the purinosome
Jarrod B. French et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
Katerina Sidera et al.
Recent Patents on Anti-Cancer Drug Discovery (2013)
Analogues of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, As Anti-Cancer Agents
Xiaokai Li et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Casticin induces ovarian cancer cell apoptosis by repressing FoxM1 through the activation of FOXO3a
Ling Jiang et al.
ONCOLOGY LETTERS (2013)
Molecular Cochaperones: Tumor Growth and Cancer Treatment
Stuart K. Calderwood
SCIENTIFICA (2013)
Inhibition of HSP70: A challenging anti-cancer strategy
Anastasia R. Goloudina et al.
CANCER LETTERS (2012)
A Novel FoxM1-Caveolin Signaling Pathway Promotes Pancreatic Cancer Invasion and Metastasis
Chen Huang et al.
CANCER RESEARCH (2012)
Cyclin-dependent kinase 4/6 inhibition in cancer therapy
Neil Johnson et al.
CELL CYCLE (2012)
The oncogenic transcription factor FOXM1 and anticancer therapy
Andrei L. Gartel
CELL CYCLE (2012)
KU-32, a Novel Drug for Diabetic Neuropathy, Is Safe for Human Islets and Improves In Vitro Insulin Secretion and Viability
Kevin Farmer et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma
Simon Pacey et al.
INVESTIGATIONAL NEW DRUGS (2012)
Ursolic acid induces apoptosis by suppressing the expression of FoxM1 in MCF-7 human breast cancer cells
Jing-song Wang et al.
MEDICAL ONCOLOGY (2012)
FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer
C. T. Karadedou et al.
ONCOGENE (2012)
ERβ1 Represses FOXM1 Expression through Targeting ERα to Control Cell Proliferation in Breast Cancer
Yoshiya Horimoto et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells
Lars Anders et al.
CANCER CELL (2011)
FoxM1: A Master Regulator of Tumor Metastasis
Pradip Raychaudhuri et al.
CANCER RESEARCH (2011)
Multiple faces of FoxM1 transcription factor Lessons from transgenic mouse models
Tanya V. Kalin et al.
CELL CYCLE (2011)
Allosteric Drugs: The Interaction of Antitumor Compound MKT-077 with Human Hsp70 Chaperones
Aikaterini Rousaki et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
HSP70 Inhibition by the Small-Molecule 2-Phenylethynesulfonamide Impairs Protein Clearance Pathways in Tumor Cells
J. I-Ju Leu et al.
MOLECULAR CANCER RESEARCH (2011)
The transcription factor FOXM1 is a cellular target of the natural product thiostrepton
Nagaratna S. Hegde et al.
NATURE CHEMISTRY (2011)
BAG3: a multifaceted protein that regulates major cell pathways
A. Rosati et al.
CELL DEATH & DISEASE (2011)
A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells
Andrew J. Massey et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Structure of the FoxM1 DNA-recognition domain bound to a promoter sequence
D. R. Littler et al.
NUCLEIC ACIDS RESEARCH (2010)
FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance
J. Millour et al.
ONCOGENE (2010)
Role of Hsp70 ATPase Domain Intrinsic Dynamics and Sequence Evolution in Enabling its Functional Interactions with NEFs
Ying Liu et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
Critical Role and Regulation of Transcription Factor FoxM1 in Human Gastric Cancer Angiogenesis and Progression
Qiang Li et al.
CANCER RESEARCH (2009)
Multi-faceted role of HSP40 in cancer
Aparna Mitra et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy
Rudi Bao et al.
CLINICAL CANCER RESEARCH (2009)
FoxM1, a critical regulator of oxidative stress during oncogenesis
Hyun Jung Park et al.
EMBO JOURNAL (2009)
Sustained NF-kappa B Activation Produces a Short-Term Cell Proliferation Block in Conjunction With Repressing Effectors of Cell Cycle Progression Controlled by E2F or FoxM1
Marianna Penzo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Novel Adenosine-Derived Inhibitors of 70 kDa Heat Shock Protein, Discovered Through Structure-Based Design
Douglas S. Williamson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Pro-proliferative FoxM1 is a target of p53-mediated repression
A. M. Barsotti et al.
ONCOGENE (2009)
Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells
Uppoor G. Bhat et al.
PLOS ONE (2009)
FoxM1 Is a General Target for Proteasome Inhibitors
Uppoor G. Bhat et al.
PLOS ONE (2009)
Deletion of Forkhead Box M1 Transcription Factor from Respiratory Epithelial Cells Inhibits Pulmonary Tumorigenesis
I-Ching Wang et al.
PLOS ONE (2009)
The proteasome: Overview of structure and functions
Keiji Tanaka
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2009)
An apoptosis-inducing small molecule that binds to heat shock protein 70
Darren R. Williams et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis
Marissa V. Powers et al.
CANCER CELL (2008)
FoxM1B Transcriptionally Regulates Vascular Endothelial Growth Factor Expression and Promotes the Angiogenesis and Growth of Glioma Cells
Yujian Zhang et al.
CANCER RESEARCH (2008)
FoxM1 inhibitors as potential anticancer drugs
Andrei L. Gartel
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression
Samuel K. M. Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness
I-Ching Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Structural basis of nucleotide exchange and client binding by the Hsp70 cochaperone Bag2
Zhen Xu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Functional coevolutionary networks of the Hsp70-Hop-Hsp90 system revealed through computational analyses
Simon A. A. Travers et al.
MOLECULAR BIOLOGY AND EVOLUTION (2007)
FOXM1c transactivates the human c-myc promoter directly via the two TATA boxes P1 and P2
Inken Wierstra et al.
FEBS JOURNAL (2006)
RB and cell cycle progression
C. Giacinti et al.
ONCOGENE (2006)
c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis
J Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Heat-shock proteins as regulators of apoptosis
S Takayama et al.
ONCOGENE (2003)
Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways
A Parcellier et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
The proteasome: structure, function, and role in the cell
J Adams
CANCER TREATMENT REVIEWS (2003)
Small heat shock proteins and stress tolerance in plants
WN Sun et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2002)
Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling
J Demand et al.
CURRENT BIOLOGY (2001)
Molecular chaperone targeting and regulation by BAG family proteins
S Takayama et al.
NATURE CELL BIOLOGY (2001)
分享论文
